Literature DB >> 10452937

Screening for cancers of the head and neck: addressing the problem.

M D Ellison1, B H Campbell.   

Abstract

More than 90% of upper aerodigestive tract (UADT) cancers occur in people with specific lifestyle risks, including tobacco and alcohol use. More than 90% of tumors occur in easily examined parts of the head and neck, therefore, there is the possibility of identifying the vast majority of patients through selective screening. Physicians should keep in mind that the mucosa's sojourn from visually suspicious (and possibly malignant) tissue is most likely less than two years, and frequent examination of asymptomatic patients is necessary. When patients wait to bring symptoms to medical attention, their cancers will be advanced 60% of the time when the chance of cure is less than 30%. Given the difficulty of implementing regular examinations in a poorly compliant, high risk population, genetic and molecular screening tools may allow very high risk individuals to be identified.

Entities:  

Mesh:

Year:  1999        PMID: 10452937

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  4 in total

1.  Demographics and efficacy of head and neck cancer screening.

Authors:  Andrew G Shuman; Payam Entezami; Anna S Chernin; Nancy E Wallace; Jeremy M G Taylor; Norman D Hogikyan
Journal:  Otolaryngol Head Neck Surg       Date:  2010-09       Impact factor: 3.497

2.  Salivary markers for oral cancer detection.

Authors:  Anastasios K Markopoulos; Evangelia Z Michailidou; Georgios Tzimagiorgis
Journal:  Open Dent J       Date:  2010-08-27

Review 3.  Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?

Authors:  Saurabh Bobdey; Ganesh Balasubramanium; Abhinendra Kumar; Aanchal Jain
Journal:  Int J Prev Med       Date:  2015-07-06

4.  Oral Microbial Species and Virulence Factors Associated with Oral Squamous Cell Carcinoma.

Authors:  Manolito G Torralba; Gajender Aleti; Weizhong Li; Kelvin Jens Moncera; Yi-Han Lin; Yanbao Yu; Michal M Masternak; Wojciech Golusinski; Pawel Golusinski; Katarzyna Lamperska; Anna Edlund; Marcelo Freire; Karen E Nelson
Journal:  Microb Ecol       Date:  2020-11-06       Impact factor: 4.552

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.